Meeting
2024 ASCO Gastrointestinal Cancers Symposium
PRECISION 1: A phase 2, multicenter, open-label basket trial of nab-sirolimus for malignant solid tumors harboring pathogenic inactivating alterations in TSC1 and TSC2.
Authors
Dustin A. Deming
University of Wisconsin Carbone Cancer Center, Madison, WI
Dustin A. Deming , David J. Kwiatkowski , Li Ding , Anita N. Schmid , Willis H. Navarro , Jordi Rodon Ahnert , Gopa Iyer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT05103358
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr TPS585)
DOI
10.1200/JCO.2024.42.3_suppl.TPS585
Abstract #
TPS585
Poster Bd #
P14
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
PRECISION 1: A phase 2, multicenter, open-label basket trial of nab-sirolimus for malignant solid tumors harboring pathogenic inactivating alterations in TSC1 and TSC2.
First Author: Gopa Iyer
Poster
2023 ASCO Annual Meeting
Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I).
First Author: Gopa Iyer
Poster
2023 ASCO Genitourinary Cancers Symposium
Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I).
First Author: Gopa Iyer
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I).
First Author: Dustin A. Deming